Localization dose and time of antigens determine immune reactivity.
about
The danger theory: 20 years laterDermaVir: a plasmid DNA-based nanomedicine therapeutic vaccine for the treatment of HIV/AIDS.Digital NFATc2 activation per cell transforms graded T cell receptor activation into an all-or-none IL-2 expression.The dominant-negative herpes simplex virus type 1 (HSV-1) recombinant CJ83193 can serve as an effective vaccine against wild-type HSV-1 infection in mice.Ectopic lymphoid organogenesis: a fast track for autoimmunityInduction of mucosal immune responses and protection of cattle against direct-contact challenge by intranasal delivery with foot-and-mouth disease virus antigen mediated by nanoparticlesUsp18 driven enforced viral replication in dendritic cells contributes to break of immunological tolerance in autoimmune diabetes.Intralymphatic immunotherapyVaccine adjuvant technology: from mechanistic concepts to practical applications.Deficiency of the B cell-activating factor receptor results in limited CD169+ macrophage function during viral infectionSequential administration of bovine and human adenovirus vectors to overcome vector immunity in an immunocompetent mouse model of breast cancerComparing the immune response to a novel intranasal nanoparticle PLGA vaccine and a commercial BPI3V vaccine in dairy calves.LJP 1082: a toleragen for Hughes syndrome.Amphiphilic polyanhydride nanoparticles stabilize Bacillus anthracis protective antigen.Broadly Neutralizing Human Immunodeficiency Virus Type 1 Antibody Gene Transfer Protects Nonhuman Primates from Mucosal Simian-Human Immunodeficiency Virus Infection.Primary hemophagocytic syndromes point to a direct link between lymphocyte cytotoxicity and homeostasis.Tumor necrosis factor family members and inflammatory bowel disease.Experimental studies of a vaccine formulation of recombinant human VEGF antigen with aluminum phosphateNeutralizing antibodies to therapeutic enzymes: considerations for testing, prevention and treatmentSafety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1.Antigen kinetics determines immune reactivity.Beyond antigens and adjuvants: formulating future vaccines.New routes for allergen immunotherapy.Functional heterogeneity of vaccine-induced CD8(+) T cells.Underwhelming the immune response: effect of slow virus growth on CD8+-T-lymphocyte responses.Combinatorial evaluation of in vivo distribution of polyanhydride particle-based platforms for vaccine delivery.Vaccine adjuvants - Current status and prospects on controlled release adjuvancity.Liver transplant tolerance and its application to the clinic: can we exploit the high dose effect?The amino acid sequences flanking an antigenic determinant can strongly affect MHC class I cross-presentation without altering direct presentation.Recent development in carbohydrate-based cancer vaccines.Conceptual Spaces of the Immune System.Mucosal Vaccine Development Based on Liposome Technology.DNA vaccines for autoimmune diseases.Towards a liquid self: how time, geography, and life experiences reshape the biological identity.Pediatric hemophagocytic syndromes: a diagnostic and therapeutic challengeTopical and mucosal liposomes for vaccine delivery.Self-tolerance in a minimal model of the idiotypic network.In situ vaccine, immunological memory and cancer cureClonal selection versus clonal cooperation: the integrated perception of immune objects.Enforced viral replication activates adaptive immunity and is essential for the control of a cytopathic virus.
P2860
Q21131221-43D41B64-B2F2-4ED7-8CBE-2C3328E4E81CQ30408029-9DD0C39C-A2FB-4D5A-AB2F-A7ADF3D21269Q33300337-152FA891-EBAA-4678-B222-84D31A4F9B36Q34150713-FAB761B0-D00A-4A36-9A29-D452B6BF2363Q34363840-8116DA56-E643-4651-88D7-973C5DC6D4B0Q34661842-9AFE2883-2BB0-473D-A9BA-42BD34D53811Q35034181-3EA8016D-8E6B-4AD3-925E-89EE1A150F7FQ35155423-67E8837A-DECF-470B-83BF-7BEC004A352FQ35192218-4D21B6A2-7149-4575-98F7-D9F52B01173AQ35489105-C105E88A-B470-417A-9568-F891BB26B83AQ35672866-F5ACD8D8-12CD-4826-B062-34B402950ECBQ35751725-5DDC3E49-6E6E-496C-BA7D-0415F15BA0D2Q35824487-6A908C73-D147-4387-8FEA-26FE0FA473C6Q35887551-EC27F5F2-E70B-489F-9874-1C66503CA13AQ35914292-B03D26A1-490B-4732-A66F-8889313EBF6EQ36015036-FDA7E9FA-56C5-4D3E-A5E3-51B2D6277DE2Q36079886-3006C91D-A5AC-44D7-9274-04C7A838FBA8Q36256394-10BCEBC5-8A23-476F-AF8D-33D282512B75Q36338254-A432FFD7-49C1-434B-9664-CBFF59640B1FQ36438711-11672A28-235D-44DE-86B2-AD40FF874F3CQ36516144-1A7F0BA9-44D8-4E0B-AE8B-70D1A17E1475Q36618500-F8F41E34-2444-407A-BCA7-9719807EE9ABQ36864957-D105AA09-B415-41B0-AE5B-151A9E48DBE0Q36908627-8143CCEA-80AB-4622-9160-2D6A56B955B8Q36954757-6D8783CA-2E4B-4AD8-A1E5-82AC83F506D5Q36957938-6A3B117B-F89D-4A69-B70D-7D11C2053D07Q37098801-7501EE7A-0C88-465C-BF77-B15BFC615B25Q37331781-70E2F627-C093-474E-9699-840063757AF6Q37372907-F701E137-4537-483D-82F5-CD63D38F5D92Q37455940-4FE1989E-B34E-4082-8C64-5F788AF3A1AAQ37496804-AC778E4A-1FE2-4DF8-BAF2-8A885AE0D8C9Q37581129-DF23E077-9F75-470E-9E01-C777CB10F4D8Q37590340-A953B040-702A-4375-8096-9B6F712F3985Q37705431-DFED2DE6-8FFB-4BED-AEA4-E2832D7F14BAQ37763298-684DDF8E-275C-46D2-9207-FB685323EDA1Q37848296-95D1A9F6-43E8-47E5-9F22-40904ADE5A7EQ38198017-B09953EC-F6C0-4594-862C-A2A64D5AB177Q38965014-9F682886-B9E0-418E-A57D-FAE7027EB567Q39200323-5D3F05C1-3D54-4EFE-A55E-14A73C577E56Q39439883-8749F04A-B20A-4343-9116-47D475F5EC0B
P2860
Localization dose and time of antigens determine immune reactivity.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Localization dose and time of antigens determine immune reactivity.
@ast
Localization dose and time of antigens determine immune reactivity.
@en
type
label
Localization dose and time of antigens determine immune reactivity.
@ast
Localization dose and time of antigens determine immune reactivity.
@en
prefLabel
Localization dose and time of antigens determine immune reactivity.
@ast
Localization dose and time of antigens determine immune reactivity.
@en
P356
P1476
Localization dose and time of antigens determine immune reactivity.
@en
P2093
Zinkernagel RM
P304
163-71; discussion 257-344
P356
10.1006/SMIM.2000.0253
P577
2000-06-01T00:00:00Z